Aktor Hamsa Nandini Nyadiakeun Pembaruan Sataun Saatos Perawatan Kanker Payudara

Hamsa Nandini kanker payudara

Bagikeun Post Ieu

2023 Pébruari: Hamsa Nandini, who was diagnosed with Grade III Invasive Carcinoma (Breast Cancer) in 2021, has updated her Instagram followers on her health status. The actress, who has appeared in Telugu films such as Mirchi and Legend, reported feeling “great.” Hamsa has also released a video discussing the changes that have occurred over the past year. Hasma is first seen in a restaurant. She appears lovely in a black dress. The accompanying text read, “One year ago…” A few seconds later, Hamsa can be seen enjoying the beach. However, she desires that the world admire her hair. “Hello, hair,” the text on it reads. Her caption read, “A great deal can occur in a year… And I am feeling good.” She chose the Michael Bublé song Feeling Good for the background music.



Euweuh urusan naon hirup throws di kuring, euweuh urusan kumaha adil sigana, Kuring nolak maén korban. Kuring nolak diparéntah ku kasieun, pesimis, sareng negativity. Kuring nolak kaluar. Kalayan kawani sareng cinta, kuring bakal maju. Manéhna nulis dina Twitter. Pariksa pos handap.

Dina Désémber 2021, Hamsa Nandini diungkabkeun diagnosis kanker payudara nya pikeun kahiji kalina. Sateuacanna, aktris éta masangkeun poto dirina sareng catetan anu panjang. Manéhna nulis, "Kuring nolak maén korban euweuh urusan naon hirup throws ka kuring atawa kumaha teu adil eta bisa muncul. Kuring nolak pikeun ngidinan sieun, pesimis, sarta negativity ngadalikeun kuring. Kuring nolak kaluar. Abdi bakal tabah kalayan kawani sareng sayang. Kuring perhatikeun benjolan leutik dina payudara kuring opat bulan ka tukang. Dina instan éta, abdi sadar yen hirup abdi moal pernah sarua. Kuring geus leungit indung kuring alatan kasakit dahsyat 18 sababaraha taun ka pengker, sarta kuring kungsi hirup di handapeun kalangkang na. Abdi sieun.”

She added, in reference to the diagnosis, “Within a couple of hours, I was at a mammography clinic having the lump examined. I was instructed to meet with a surgical oncologist immediately, who recommended a biopsy. The biopsy confirmed my worst fears, and I was diagnosed with kanker payudara of grade III invasiveness.

Saatos ngaleungitkeun tumorna, Hamsa Nandini was diagnosed with Grade III invasive carcinoma (breast cancer). She stated, “The relief was only momentary as I tested positive for BRCA1 (hereditary breast cancer). This indicates that I have a genetic mutation that virtually guarantees a 70% chance of developing breast cancer and a 45% chance of developing ovarian cancer in the future. Before I can claim victory, the only way to mitigate the risk is to undergo a series of extensive preventative surgeries. I have already completed 9 cycles of chemotherapy and have 7 more to go.”

Ngalanggan Pikeun Newsletter kami

Meunang apdet sarta pernah sono blog ti Cancerfax

Langkung Kanggo Ngajalajah

Terapi Sél CAR T Berbasis Manusa: Terobosan sareng Tantangan
Terapi T-Cell mobil

Terapi Sél CAR T Berbasis Manusa: Terobosan sareng Tantangan

Terapi CAR T-sél basis manusa revolutionizes pengobatan kanker ku genetik modifying sél imun hiji sabar urang sorangan pikeun sasaran sarta ngancurkeun sél kanker. Ku ngamangpaatkeun kakuatan sistem imun awak, terapi ieu nawiskeun pangobatan anu kuat sareng pribadi sareng poténsial pikeun remisi anu berkepanjangan dina sababaraha jinis kanker.

Ngartos Sindrom Pelepasan Sitokin: Nyababkeun, Gejala, sareng Pangobatan
Terapi T-Cell mobil

Ngartos Sindrom Pelepasan Sitokin: Nyababkeun, Gejala, sareng Pangobatan

Cytokine Release Syndrome (CRS) mangrupikeun réaksi sistem imun anu sering dipicu ku sababaraha pangobatan sapertos immunotherapy atanapi terapi sél CAR-T. Éta ngalibatkeun sékrési sitokin anu kaleuleuwihan, nyababkeun gejala mimitian ti muriang sareng kacapean dugi ka komplikasi anu ngancam kahirupan sapertos karusakan organ. Manajemén butuh strategi ngawaskeun sareng intervensi anu ati-ati.

Peryogi bantosan? Tim kami siap ngabantosan anjeun.

Kami ngarepkeun pamulihan gancang tina anu anjeun sayogi sareng anu caket.

Mimitian obrolan
Kami Online! Ngobrol Jeung Kami!
Scan kode na
Halo,

Wilujeng sumping di CancerFax!

CancerFax mangrupikeun platform pioneering anu didedikasikeun pikeun ngahubungkeun individu anu nyanghareupan kanker tahap lanjut kalayan terapi sél anu inovatif sapertos terapi CAR T-Cell, terapi TIL, sareng uji klinis di sakuliah dunya.

Hayu urang nyaho naon bisa urang pigawé pikeun anjeun.

1) Pangobatan kanker di luar negeri?
2) Terapi T-Sél mobil
3) Vaksin kanker
4) Konsultasi video online
5) Terapi proton